Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Shareholders Approve Second Tranche of Private Placement, Reverse Stock Split

NEW YORK (GenomeWeb News) – CombiMatrix announced after the close of the market on Tuesday that shareholders approved the second tranche of a private placement that seeks to raise $2.5 million in total.

Shareholders also approved a one-for-10 reverse stock split, the Irvine, Calif.-based company said.

The private placement of CombiMatrix's Series A Preferred Stock was announced in October, and the firm said on Tuesday that it raised gross proceeds of $1.05 million in the first tranche. Approval for the second tranche was approved at a special meeting of shareholders on Nov. 29.

Shareholders also approved the reverse stock split, which became effective at the close of business on Tuesday. A one-for-10 reverse split of CombiMatrix's Nasdaq-listed warrants occurred at the same time.

The reverse split was carried out in order for CombiMatrix to comply with Nasdaq listing requirements, it said. During the summer Nasdaq warned the company that it was not in compliance with a requirement calling for minimum bid of $1 per share for at least 30 consecutive business days.

The reverse split increases the number of shares that CombiMatrix has for issuance.

It said that it expects its split-adjusted shares of common stock and split-adjusted Nasdaq-listed warrants to begin trading on the Nasdaq Capital Market at the start of the trading day on Dec. 5.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.